DAC HYP compositions and methods
US9676860B2 · kind B2 · utility
6Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2015 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Jul 6, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.